Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/25/22
End: 10/31/27
Due: 10/31/28
Phase: N/A
Priority: Normal
Start: 02/25/24
End: 12/25/28
Due: 12/25/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients | NCT06066008 | Zhongmou Therapeutics | user2@example.com | None | 2022-09-25 | 2027-10-31 | 2028-10-31 | - | - | 2025-07-14 |
| Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients | NCT06292650 | Zhongmou Therapeutics | user2@example.com | None | 2024-02-25 | 2028-12-25 | 2029-12-25 | - | - | 2025-07-14 |